Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
95% Confidence Interval
27%
Adaptation
8%
Aging
9%
Alzheime's Disease
6%
Alzheimer's Disease
6%
Antibiotics
7%
Anxiety Disorders
7%
Asthma
18%
Atrial Fibrillation
10%
Attention Deficit Hyperactivity Disorder
8%
Bacillus Subtilis (B. subtilis)
7%
BESIII Detector
8%
Blood Pressure
8%
Body Mass Index
8%
Branching Fraction
14%
Breast Cancer
8%
Cancer Patients
10%
Cardiac Magnetic Resonance Imaging (cMRI)
7%
Cardiovascular Disease
10%
Chemotherapy
8%
China
7%
Chronic Kidney Disease
12%
Chronic Obstructive Pulmonary Disease
14%
Clinical Outcomes
12%
Clinical Practice
10%
Clinical Trials
10%
Comorbidity
10%
Computed Tomography
7%
Cost-effectiveness
12%
COVID-19
22%
CRISTAL
10%
Depressive Symptoms
12%
Diabetes
9%
During Pregnancy
7%
Dust
7%
Dutch
83%
Energy Center
11%
Escherichia Coli
10%
Europe
24%
European Countries
7%
Galaxies
47%
Gasses
15%
Gene Expression
8%
General Practitioners
7%
Genome-wide Association Study
8%
Germany
9%
Groningen
20%
Halo
9%
Hazard Ratio
13%
Head-and-neck Cancer
8%
Health-related Quality of Life
11%
Healthcare Professionals
8%
Healthy Controls
10%
Heart Failure
20%
Heart Failure with Preserved Ejection Fraction (HFpEF)
9%
High Risk
13%
In Cancer
7%
Indonesia
6%
Inflammation
11%
Inflammatory Bowel Disease
8%
Integrated Luminosity
9%
Kidney
8%
Kinematics
9%
Lactococcus Lactis (L. lactis)
7%
Law
7%
Liver
11%
Lung
7%
Maar
8%
Major Depressive Disorder
8%
Meta-analysis
37%
Metabolism
7%
Multiple Sclerosis
7%
Myocardial Infarction
6%
Netherlands
100%
Obesity
9%
Odds Ratio
14%
Older Adults
19%
Overall Survival
9%
Parkinson's Disease
7%
Patients with Heart Failure
9%
Pharmacokinetics
7%
Physical Activity
9%
Placebo
13%
Positron Emission Tomography/computed Tomography (PET/CT)
13%
Primary Care
10%
Prospective Cohort Study
9%
Proton
9%
Quality of Life
24%
Radio
9%
Radiotherapy
10%
Randomized Controlled Trial
23%
Risk Factors
20%
Schizophrenia
7%
Star Formation
10%
Transplantation
8%
Tumor
15%
Type 2 Diabetes Mellitus (T2DM)
15%
Type 2 Diabetic Patients
8%
Well-being
9%
X-ray
7%